NXTCL.ST
NextCell Pharma AB
Price:  
1.74 
SEK
Volume:  
519,074.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NXTCL.ST WACC - Weighted Average Cost of Capital

The WACC of NextCell Pharma AB (NXTCL.ST) is 6.2%.

The Cost of Equity of NextCell Pharma AB (NXTCL.ST) is 6.80%.
The Cost of Debt of NextCell Pharma AB (NXTCL.ST) is 7.00%.

Range Selected
Cost of equity 5.60% - 8.00% 6.80%
Tax rate 20.60% - 20.90% 20.75%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.6% - 6.8% 6.2%
WACC

NXTCL.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.61 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.60% 8.00%
Tax rate 20.60% 20.90%
Debt/Equity ratio 1 1
Cost of debt 7.00% 7.00%
After-tax WACC 5.6% 6.8%
Selected WACC 6.2%